Last reviewed · How we verify
Control (Standard treatment)
Control (Standard treatment) is a Small molecule drug developed by Henry Ford Health System. It is currently FDA-approved. Also known as: Group B, 3- Third group: control group will receive NSAIDs, steroids and paracetamol as standard post tonsillectomy medications in our department., Zinc Oxide Barrier Cream.
Control represents standard medical treatment or usual care provided as a comparator in clinical trials.
Control in clinical trials for Control (Standard treatment) has been compared to a Sham group in studies on Locally Advanced Rectal Cancer, Traumatic Brain Injury, Acute Ischemic Stroke, and Artificial Intelligence (AI), as well as Endovascular Thrombectomy. In the study "The Effect of Cancer Therapies and Exercise on Mitochondrial Energetics and Fitness", Control was compared to a Structured responsive interval exercise training programme.
At a glance
| Generic name | Control (Standard treatment) |
|---|---|
| Also known as | Group B, 3- Third group: control group will receive NSAIDs, steroids and paracetamol as standard post tonsillectomy medications in our department., Zinc Oxide Barrier Cream |
| Sponsor | Henry Ford Health System |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
As a control arm in clinical research, 'Control (Standard treatment)' does not refer to a specific drug with a defined mechanism of action. Instead, it represents the baseline or conventional therapeutic approach used at Henry Ford Health System against which investigational treatments are compared. The specific mechanism depends entirely on what standard treatment is being administered for the particular condition being studied.
Approved indications
Common side effects
Key clinical trials
- A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) (PHASE2)
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection (PHASE1, PHASE2)
- Shared Decision-Making Decision Aid for Newly Diagnosed Breast Cancer : A Multi-Center Randomized Controlled Trial (NA)
- Project Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair (NA)
- A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (PHASE3)
- Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation (NA)
- Bedside Bike Early Mobilization Program for Inpatients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Control (Standard treatment) CI brief — competitive landscape report
- Control (Standard treatment) updates RSS · CI watch RSS
- Henry Ford Health System portfolio CI
Frequently asked questions about Control (Standard treatment)
What is Control (Standard treatment)?
How does Control (Standard treatment) work?
Who makes Control (Standard treatment)?
Is Control (Standard treatment) also known as anything else?
What development phase is Control (Standard treatment) in?
Related
- Manufacturer: Henry Ford Health System — full pipeline
- Also known as: Group B, 3- Third group: control group will receive NSAIDs, steroids and paracetamol as standard post tonsillectomy medications in our department., Zinc Oxide Barrier Cream
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing